Sparta Commercial Services (SRCO) 10-Q 23 Dec 24 2025 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Oct. 31, 2024	Dec. 23, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Oct. 31, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--04-30
Entity File Number	0-9483
Entity Registrant Name	SPARTA COMMERCIAL SERVICES, INC.
Entity Central Index Key	0000318299
Entity Tax Identification Number	30-0298178
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	555 Fifth Avenue
Entity Address, Address Line Two	14th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	(212)
Local Phone Number	239-2666
Title of 12(b) Security	Common stock, $.001 par value
Trading Symbol	SRCO
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		37,863,288

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Current Assets
Cash and cash equivalents	$ 93,840	$ 100,953
Accounts receivable	3,081	6,724
Inventory	6,163	3,004
Loans receivable	523,766
Total Current Assets	626,850	110,681
Deposits - rent deposit	9,000	9,000
Total assets	635,850	119,681
Current Liabilities
Accounts payable and accrued expenses	1,318,643	1,208,195
Short Term Loan	1,585	1,585
Current portion notes payable	7,485,493	7,168,481
Derivative liabilities	1,019,644	740,940
Total Current Liabilities	10,460,684	9,756,278
Notes payable- net of current portion	341,829
Total Long Term Liabilities	341,829
Total liabilities	10,802,513	9,756,278
Stockholders’ Deficit:
Common stock, $0.001 par value; 750,000,000 shares authorized, and 36,210,837 and 29,495,189 shares issued and outstanding as of October 31, 2024 and April 30, 2024, respectively	36,211	29,495
Common stock to be issued 33,490,238 and 33,395,883 as of October 31, 2024 and April 30, 2024, respectively	34,174	33,396
Additional paid-in-capital	56,592,040	55,870,123
Additional paid-in-capital- reserves	327,224	204,385
Accumulated deficit	(68,176,055)	(66,795,350)
Total deficiency in stockholders’ equity	(11,171,586)	(10,643,131)
Non-controlling interest	1,004,923	1,006,534
Total Deficit	(10,166,663)	(9,636,597)
Total Liabilities and Deficit	635,850	119,681
Series A Convertible Preferred Stock [Member]
Stockholders’ Deficit:
Preferred stock, value	12,500	12,500
Series C Redeemable Convertible Preferred Stock [Member]
Stockholders’ Deficit:
Preferred stock, value	1,919	1,919
Series D Redeemable Convertible Preferred Stock [Member]
Stockholders’ Deficit:
Preferred stock, value	401	401
Related Party [Member]
Current Liabilities
Loans payable-related parties	$ 635,319	$ 637,077

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Oct. 31, 2024	Apr. 30, 2024
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	750,000,000	750,000,000
Common stock, shares issued	36,210,837	29,495,189
Common stock, shares outstanding	36,210,837	29,495,189
Common stock to be issued	33,490,238	33,395,883
Series A Convertible Preferred Stock [Member]
Preferred stock, par value	$ 100	$ 100
Preferred stock, shares designated	35,850	35,850
Preferred stock, shares issued	125	125
Preferred stock, shares outstanding	125	125
Series C Redeemable Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	4,200,000	4,200,000
Preferred stock, shares issued	1,919,157	1,919,157
Preferred stock, shares outstanding	1,919,157	1,919,157
Preferred stock, liquidation and redemption value per share	$ 1	$ 1
Series D Redeemable Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	2,000,000	2,000,000
Preferred stock, shares issued	400,877	400,877
Preferred stock, shares outstanding	400,877	400,877
Preferred stock, liquidation and redemption value per share	$ 1	$ 1

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Revenue
Total Revenue	$ 47,808	$ 52,418	$ 89,359	$ 114,697
Less Cost of goods sold	4,654	14,135	13,237	23,059
Gross profit	43,154	38,283	76,122	91,638
Operating expenses:
Compensation and related costs	174,066	138,697	388,196	299,792
Accounting and legal Fees	23,670	44,510	47,890	45,650
Consulting fees	105,315	14,400	179,375	34,890
Rent and lease	18,000	18,000	36,000	36,000
General office expenses	50,999	89,239	97,351	203,551
Total operating expenses	372,050	304,846	748,812	619,883
Loss from operations	(328,896)	(266,563)	(672,690)	(528,245)
Other (income) expense:
Commission on Municipal Bonds	(7,489)	(3,166)	(9,993)	(3,897)
Financing costs	207,976	144,481	452,910	284,867
Write off convertible notes		(21,364)		(60,789)
Loss (gain) in changes in fair value of derivative liability	(99,588)	(24,095)	278,704	(177,373)
Other income	(11,995)		(11,995)
Total other (income) expense	88,904	95,856	709,626	42,808
Net income (loss)	(417,800)	(362,419)	(1,382,316)	(571,053)
Net profit attibutable to minority shareholder	268	(1,972)	1,611	(4,681)
Preferred dividend
Net income (loss) attributed to common stockholders	$ (417,532)	$ (364,391)	$ (1,380,705)	$ (575,734)
Basic and diluted loss per share:
Income (Loss) from continuing operations attributable to Sparta Commercial Services, Inc. common stockholders, basic	$ (0.01)	$ (0.01)	$ (0.04)	$ (0.02)
Income (Loss) from continuing operations attributable to Sparta Commercial Services, Inc. common stockholders, diluted	(0.01)	(0.01)	(0.04)	(0.02)
Net loss attributable to Sparta Commercial Services, Inc. common stockholders, basic	(0.01)	(0.01)	(0.04)	(0.02)
Net loss attributable to Sparta Commercial Services, Inc. common stockholders, diluted	$ (0.01)	$ (0.01)	$ (0.04)	$ (0.02)
Weighted average shares outstanding, basic	35,388,095	24,323,456	32,872,509	24,323,456
Weighted average shares outstanding, diluted	35,388,095	24,323,456	32,872,509	24,323,456
Information Technology [Member]
Revenue
Total Revenue	$ 27,695	$ 42,875	$ 62,039	$ 98,071
Wellness Products [Member]
Revenue
Total Revenue	6,120	9,543	11,182	16,626
Merchant Financing [Member]
Revenue
Total Revenue	$ 13,993		$ 16,138

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholder's Deficits - USD ($)	Series A Preferred Stock [Member] Preferred Stock [Member]	Series C Preferred Stock [Member] Preferred Stock [Member]	Series D Preferred Stock [Member] Preferred Stock [Member]	Common Stock [Member]	Common Stock to be Issued [Member]	Additional Paid in Capital (Reserves) [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Balance at Apr. 30, 2023	$ 12,500	$ 1,979	$ 938	$ 23,045	$ 23,705		$ 54,872,206	$ (66,150,857)	$ 969,295	$ (10,247,189)
Balance, shares at Apr. 30, 2023	125	1,979,157	937,701	23,045,205	23,704,788
Issuance of common shares for cash					$ 1,133		103,867			105,000
Issuance of common shares for cash, shares					1,132,910
Issuance of shares for services				$ 831	$ (831)		69,169			69,169
Issuance of shares for services, shares				830,906	(830,906)
Net loss								(211,343)	2,709	(208,634)
Stocks issued as a note holder incentive				$ 75			6,900			6,975
Stocks issued as a note holder incentive, shares				75,000
Balance at Jul. 31, 2023	$ 12,500	$ 1,979	$ 938	$ 23,951	$ 24,007		55,052,142	(66,362,200)	972,004	(10,274,679)
Balance, shares at Jul. 31, 2023	125	1,979,157	937,701	23,951,111	24,006,792
Balance at Apr. 30, 2023	$ 12,500	$ 1,979	$ 938	$ 23,045	$ 23,705		54,872,206	(66,150,857)	969,295	(10,247,189)
Balance, shares at Apr. 30, 2023	125	1,979,157	937,701	23,045,205	23,704,788
Net loss										(571,053)
Balance at Oct. 31, 2023	$ 12,500	$ 1,979	$ 938	$ 24,323	$ 24,702		55,149,603	(66,726,591)	973,976	(10,538,570)
Balance, shares at Oct. 31, 2023	125	1,979,157	937,701	24,323,106	24,701,797
Balance at Apr. 30, 2023	$ 12,500	$ 1,979	$ 938	$ 23,045	$ 23,705		54,872,206	(66,150,857)	969,295	(10,247,189)
Balance, shares at Apr. 30, 2023	125	1,979,157	937,701	23,045,205	23,704,788
Balance at Apr. 30, 2024	$ 12,500	$ 1,919	$ 401	$ 29,495	$ 33,396	204,385	55,870,123	(66,795,350)	1,006,534	(9,636,597)
Balance, shares at Apr. 30, 2024	125	1,919,157	400,877	29,495,189	33,395,883
Balance at Jul. 31, 2023	$ 12,500	$ 1,979	$ 938	$ 23,951	$ 24,007		55,052,142	(66,362,200)	972,004	(10,274,679)
Balance, shares at Jul. 31, 2023	125	1,979,157	937,701	23,951,111	24,006,792
Issuance of common shares for cash					$ 988		64,012			65,000
Issuance of common shares for cash, shares					988,000
Issuance of shares for services				$ 25			3,850			3,875
Issuance of shares for services, shares				25,000
Net loss								(364,391)	1,972	(362,419)
Stocks issued as a note holder incentive					$ 54		4,946			5,000
Stocks issued as a note holder incentive, shares					54,000
Stock issued for equity				$ 347	$ (347)		24,653			24,653
Stock issued for equity, shares				346,995	(346,995)
Balance at Oct. 31, 2023	$ 12,500	$ 1,979	$ 938	$ 24,323	$ 24,702		55,149,603	(66,726,591)	973,976	(10,538,570)
Balance, shares at Oct. 31, 2023	125	1,979,157	937,701	24,323,106	24,701,797
Balance at Apr. 30, 2024	$ 12,500	$ 1,919	$ 401	$ 29,495	$ 33,396	204,385	55,870,123	(66,795,350)	1,006,534	(9,636,597)
Balance, shares at Apr. 30, 2024	125	1,919,157	400,877	29,495,189	33,395,883
Subscribed shares issued				$ 408	$ (408)
Subscribed shares issued, shares				408,250	(408,250)
Issuance of common shares for cash				$ 1,972	$ 1,814		331,214			335,000
Issuance of common shares for cash, shares				1,971,673	1,813,590
Issuance of shares for services				$ 200			22,800			23,000
Issuance of shares for services, shares				200,000
Conversion of notes payable				$ 750			74,250			75,000
Conversion of notes payable, shares				750,000
Warrants issued on equity issuance						72,558				72,558
Commitment Shares not yet issued					$ 200		18,440			18,640
Commitment Shares not yet issued, shares					200,000
Net loss								(963,173)	(1,343)	(964,516)
Balance at Jul. 31, 2024	$ 12,500	$ 1,919	$ 401	$ 32,825	$ 35,002	276,943	56,316,827	(67,758,523)	1,005,191	(10,076,915)
Balance, shares at Jul. 31, 2024	125	1,919,157	400,877	32,825,112	35,001,223
Balance at Apr. 30, 2024	$ 12,500	$ 1,919	$ 401	$ 29,495	$ 33,396	204,385	55,870,123	(66,795,350)	1,006,534	(9,636,597)
Balance, shares at Apr. 30, 2024	125	1,919,157	400,877	29,495,189	33,395,883
Net loss										(1,382,316)
Balance at Oct. 31, 2024	$ 12,500	$ 1,919	$ 401	$ 36,211	$ 34,174	327,224	56,592,040	(68,176,055)	1,004,923	(10,166,663)
Balance, shares at Oct. 31, 2024	125	1,919,157	400,877	36,210,837	33,490,238
Balance at Jul. 31, 2024	$ 12,500	$ 1,919	$ 401	$ 32,825	$ 35,002	276,943	56,316,827	(67,758,523)	1,005,191	(10,076,915)
Balance, shares at Jul. 31, 2024	125	1,919,157	400,877	32,825,112	35,001,223
Subscribed shares issued				$ 2,827	$ (2,827)
Subscribed shares issued, shares				2,826,908	(2,826,908)
Issuance of common shares for cash				$ 50	$ 1,999		210,451			212,500
Issuance of common shares for cash, shares				50,014	1,315,923
Issuance of shares for services				$ 154			54,862			55,016
Issuance of shares for services, shares				153,956
Conversion of notes payable				$ 100			9,900			10,000
Conversion of notes payable, shares				100,000
Warrants issued on equity issuance						50,281				50,281
Net loss								(417,532)	(268)	(417,800)
Default shares issued				$ 255						255
Default shares issued, shares				254,847
Balance at Oct. 31, 2024	$ 12,500	$ 1,919	$ 401	$ 36,211	$ 34,174	$ 327,224	$ 56,592,040	$ (68,176,055)	$ 1,004,923	$ (10,166,663)
Balance, shares at Oct. 31, 2024	125	1,919,157	400,877	36,210,837	33,490,238

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income ( loss )	$ (1,382,316)	$ (571,053)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss (Gain) from change in fair value of derivative liabilities	278,704	(177,373)
Non-cash financing cost	270,937	284,867
Shares issued for services	78,016
Stocks issued as note holder incentive	18,895
Forgiveness of debt		(60,789)
Changes in operating assets and liabilities
Accounts receivable	3,643	(870)
Inventory	(3,159)	(2,022)
Loans receivable	(523,766)
Accounts payable and accrued expenses	258,183	87,425
Net cash used in operating activities	(1,000,863)	(439,815)
CASH FLOWS FROM INVESTING ACTIVITIES:
CASH FLOWS FROM FINANCING ACTIVITIES
Bank overdraft		888
Proceeds from sale of stock	547,500	105,461
Stocks issued for equity		175,000
Net Proceeds from notes payable	448,008	159,000
Repayment of related party loans	(1,758)
Net cash provided by financing activities	993,750	440,349
Net (decrease) increase in cash	(7,113)	534
Cash and cash equivalents, beginning of period	100,953	4,028
Cash and cash equivalents , end of period	93,840	4,562
Cash paid for:
Interest
Income taxes

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE A – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES A summary of the significant accounting policies applied in the preparation of the accompanying unaudited condensed consolidated financial statements follows. Business General Overview Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation with headquarters in New York City, (www.spartacommercial.com) Sparta’s roots are in the Powersports industry. The Company provided retail installment loans and leases through authorized motorcycle dealerships in 33 states, with financing provided by institutional lenders. The Company also maintained a full underwriting and servicing platform for its portfolio. Notwithstanding the discontinuance of our initial focus on consumer loans and leases post Lehman and during the 2008 financial crisis, in 2007, the Company introduced a new initiative, Municipal Financing (www.spartamunicipal.com), which has financed over 100 jurisdictions to date. Sparta’s Municipal Finance program is available to all nonprofit organizations, institutions, and entities. All nonprofit organizations which adhere to I.R.S. guidelines, including 501 (c) 3 of the Internal Revenue Code, are eligible. Both public nonprofits, also known as public charities supported with publicly collected funds, and private nonprofits, also known as private foundations backed by an individual or business entity, qualify for the program.. Consumers, retailers, municipals, nonprofits, auction houses, banks, and insurance companies scrutinize title history reports for the vital information needed and factored into crucial business decisions affecting the bottom line. Vehicle History Reports are a staple of Sparta’s E-Commerce Technology subsidiary iMobile Solutions, Inc. Whether a vehicle is intended for business or recreational use, Sparta’s Vehicle History Reports are highly regarded for accuracy and completeness. They have been sold across all 50 states and in 62 countries worldwide. They provide a trusted layer of assurance to vehicle buyers and are available on our websites as well as on various dealership websites. They include Cyclechex (Motorcycle History Reports at www.cyclechex.com), RVchex (Recreational Vehicle History Reports at www.rvchex.com), and Truckchex (Heavy Duty Truck History Reports at www.truckchex.com The Company’s E-Commerce and Mobile Technology subsidiary name change to iMobile Solutions, Inc., from Specialty Reports, Inc., in 2016, signifies its ever-broadening service offerings in the evolving technology landscape. With iMobile App (www.imobileapp.com), the Company provides mobile technology services, including web and mobile application creation, development, and management for a wide range of businesses to increase revenue, build brand recognition, and improve customer engagement. Our ever-broadening business base of mobile applications includes vehicle dealerships and racetracks, private clubs and country clubs, schools and entertainment venues, restaurants, grocery stores, and various other merchant types. (www.imobileapp.com/app-gallery). The Company also designs, launches, maintains, and hosts websites for businesses incorporating SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development, and integration. This custom software helps businesses communicate with customers and can also be used for employees to communicate internally. The CRM software can be web-based, integrated with a mobile app, or both. We work with clients to understand their unique needs and incorporate the features and requirements that are most important to them and will facilitate their business growth and success. Correspondingly, the Company designs and builds custom kitchen ordering software for independent grocery stores, delicatessens, and other food service businesses. The software can be designed in various ways, including mobile devices and in-store ordering. The kitchen ordering software is enabled with payment integration, text messaging notification, wireless printing, and other features. iMobile Solutions, Inc. provides a turn-key solution for businesses looking to simplify or streamline their kitchen ordering process. Additionally, we offer text messaging services, which supplement business marketing strategies to gain and retain brand loyalty among its clients, customers, and investors. Our text messaging platform allows clients to manage, schedule, and analyze text message performance quickly. Sparta’s response to the onset of the COVID-19 pandemic in early 2020 quickly took shape with thorough investigations into evolving customer trends in health and wellness. As a result, we expanded New World Health Brands and developed a new product line of natural dietary supplements. In August 2020, we launched an online B to C website: www.newworldhealthbrands.com Sparta’s subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com, was established in September 2020, and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform is scheduled to launch in 2023 and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com Agoge Global USA, Inc. was formed as a subsidiary of Sparta Crypto, Inc. in December 2022 and entered into a Joint Venture Agreement with WeDev Group to facilitate cross-border transactions between importers and exporters of goods from the U.S. and Brazil. In addition, Agoge Global USA provides business intermediary services to global importers and exporters of goods and services. These services provided through our joint venture agreement with WeDev include, but are not limited to, industry introductions, tax and regulatory compliance assistance, import and export documentation assistance, reselling services in other jurisdictions, and facilitation of cross-border transactions. Basis of Presentation The accompanying unaudited condensed consolidated financial statements as of October 31, 2024 and for the three months ended October 31, 2024 and 2023 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, including Form 10-Q and Regulation S-K. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments), which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. The Company believes that the disclosures provided are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and explanatory notes for the year ended April 30, 2024 as disclosed in the Company’s Form 10-K for that year as filed with the Securities and Exchange Commission on August 14, 2024. The results of operations for the three months ended October 31, 2024 are not necessarily indicative of the results to be expected for any other interim period or the full year ending April 30, 2025. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation. The third-party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of changes in deficit. Estimates These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and the disclosures of revenues and expenses for the said period. Accordingly, actual results could differ from those estimates. Revenue Recognition Revenue is recognized in accordance with Accounting Standards Codification (“ASC”) Revenue from Contracts with Customers The Company acts as a principal in its revenue transactions as it is the primary obligor. SCHEDULE OF DISAGGREGATION REVENUE Revenue October 31, 2024 July 31, 2024 Three months ended Revenue October 31, 2024 July 31, 2024 Information technology $ 27,695 $ 34,344 New World Health 6,120 5,062 Merchant financing 13,993 2,145 Total $ 47,808 $ 41,551 Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are typically recognized upon delivery/download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due before our performance, including refundable amounts. Revenues from merchant financing is recognized over the life of the contracts. Cash Equivalents All liquid investments with three months or less maturity are cash equivalents for the accompanying financial statements. Website Development Costs The Company recognizes website development costs in accordance with ASC 350-50, “Accounting for Website Development Costs.” Fair Value Measurements The Company has adopted ASC 820, “Fair Value Measurements .” ● Level 1 — ● Level 2 — ● Level 3 — This hierarchy requires the Company to use observable market data when available and to minimize the use of unobservable inputs when determining fair value. Observable inputs may not always be available for some products or in certain market conditions. Income Taxes We utilize ASC 740, “ Income Taxes The Company recognizes the impact of a position in the financial statements only if that position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position. Our practice recognizes interest or penalties related to income tax matters in income tax expense. Stock-Based Compensation We account for our stock-based compensation under ASC 718 “ Compensation–Stock Compensation We use the fair value method for equity instruments granted to non-employees and the Black-Scholes model to measure options’ fair value. The stock-based fair value compensation is determined as of the date of the grant or at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. Inventories The Company’s inventories represent finished goods, consisting of available products. They are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health business. Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents, and receivables. The Company places its cash and temporary cash investments with high-credit quality institutions. At times, such investments may be more than the FDIC insurance limit. Net Loss Per Share The Company uses ASC 260-10, “ Earnings Per Share Derivative Liabilities The Company assessed the classification of its derivative financial instruments as of October 31, 2024, and April 30, 2024, which consist of convertible instruments and rights to shares of the Company’s common stock. It determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed conventional, as described. Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “ Accounting for Derivative Instruments and Hedging Activities The Company assessed the classification of its derivative financial instruments as of October 31, 2024 and April 30, 2024, which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described. Reclassifications Certain reclassifications have been made to conform with prior periods’ data to the current presentation. These reclassifications did not affect reported losses. Recent Accounting Pronouncements No recent pronouncements have been made or adopted in the quarter ended October 31, 2024. All of the pronouncements that affect our business have been adopted.

GOING CONCERN MATTERS

GOING CONCERN MATTERS	6 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN MATTERS	NOTE B – GOING CONCERN MATTERS The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying unaudited condensed consolidated financial statements, the Company has incurred recurring losses and generated negative cash flows from operating activities since inception. As of October 31, 2024, the Company had an accumulated deficit of $ 68,176,055 9,833,834 The Company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that the Company’s efforts will be successful. No assurance can be given that management’s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern. In order to improve the Company’s liquidity, the Company’s management is actively pursuing additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing. The Company’s existence depends on management’s ability to develop profitable operations. Management is devoting substantially all its efforts to growing its business and raising capital, and there can be no assurance that the Company’s efforts will be successful. The management’s actions are not guaranteed to result in profitable operations or resolve liquidity problems. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern. The Company’s management actively pursues additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing.

NOTES PAYABLE AND DERIVATIVES

NOTES PAYABLE AND DERIVATIVES	6 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
NOTES PAYABLE AND DERIVATIVES	NOTE C – NOTES PAYABLE AND DERIVATIVES The Company has numerous outstanding notes payable to various parties. The notes bear interest at rates of 5 20 SCHEDULE OF NOTES PAYABLE Notes Payable October 31, 2024 April 30, 2024 Notes convertible at holder’s option $ 2,231,197 $ 2,723,197 Notes convertible at Company’s option 335,700 335,700 Non-convertible notes payable 2,913,400 2,399,221 Accrued interest 2,005,196 1,710,363 Notes payable current 7,485,493 7,168,481 Add non-current portion 341,829 - Total $ 7,827,322 $ 7,168,481 Certain notes payable contain variable conversion rates, and the conversion features are classified as derivative liabilities. The conversion prices are based on the market price of the Company’s common stock, at discounts of 60 The Company’s derivative financial instruments are embedded derivatives related to the outstanding short-term Convertible Notes Payable. These embedded derivatives included certain conversion features indexed to the Company’s common stock. The accounting treatment of derivative financial instruments requires that the Company record the derivatives and related items at their fair values as of the inception date of the Convertible Notes Payable and at fair value as of each subsequent balance sheet date. In addition, under the provisions of Accounting Standards Codification subtopic 815-40, Derivatives and Hedging; Contracts in Entity’s Own Equity (“ASC 815-40”), as a result of entering into the Convertible Notes Payable, the Company is required to classify all other non-employee stock options and warrants as derivative liabilities and mark them to market at each reporting date. Any change in fair value, including modifications of terms, will be recorded as non-operating, non-cash income, or expense at each reporting date. If the fair value of the derivatives is higher at the subsequent balance sheet date, the Company will record a non-operating, non-cash charge. If the fair value of the products is lower at the subsequent balance sheet date, the Company will record non-operating, non-cash income. These Notes are subject to a six-year Statute of Limitations in which to bring any potential claims. The change in fair value of the derivative liabilities on October 31, 2024, was calculated with the following average assumptions using a binomial option pricing model are as follows: SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BINOMIAL OPTION Significant Assumptions: Risk-free interest rate 4.28 % Expected stock price volatility 125 % Expected dividend payout 0 Expected life in years 1 Changes in derivative liability during the three months ended October 31, 2024, and 2023 were: 1,019,644 SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES October 31, October 31, 2024 2023 Balance, beginning of year $ 1,119,232 $ 1,375,767 Balance $ 1,119,232 $ 1,375,767 Derivative liability extinguished - (100,797 ) Derivative financial liability arising on the issuance of convertible notes and warrants - - Fair value adjustments (99,588 ) (76,576 ) Balance, end of period $ 1,019,644 $ 1,198,394 Balance $ 1,019,644 $ 1,198,394

LOANS PAYABLE TO RELATED PARTIE

LOANS PAYABLE TO RELATED PARTIES	6 Months Ended
	Oct. 31, 2024
Related Party Transactions [Abstract]
LOANS PAYABLE TO RELATED PARTIES	NOTE D – LOANS PAYABLE TO RELATED PARTIES As of October 31, 2024, and April 30, 2024, aggregated loans and notes payable, without demand and with interest from 0 12 635,319 637,077

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS	6 Months Ended
	Oct. 31, 2024
Equity [Abstract]
EQUITY TRANSACTIONS	NOTE E EQUITY TRANSACTIONS Preferred Stock The Company is authorized to issue 10,000,000 0.001 35,850 100 1,000 10,000 4,200,000 1.00 2,000,000 1 Common Stock The Company is authorized to issue 750,000,000 0.001 36,210,837 29,495,189 33,490,238 33,395,883 During the six months ended October 31, 2024, the Company: ● Issued 3,043,232 2,107,968 547,500 ● Issued 153,956 55,016 ● 579,847 42,890 ● Issued 850,000 85,000 During the six months ended October 31, 2023, the Company: ● Issued 1,178,251 95,000 ● Issued 25,000 3,875 ● Issued 75,000 6,975 ● Sold to five accredited investors 1,127,372 85,000

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE F – FAIR VALUE MEASUREMENTS The Company follows the guidelines established according to ASC 820, which established a framework for measuring fair value and expands disclosure about fair value measurements. ASC 820 defines fair value as the amount received for an asset or paid to transfer a liability (i.e., an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes the following three levels of inputs that may be used: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets and liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data. Level 3: Unobservable inputs when there is little or no market data available, thereby requiring an entity to develop its own assumptions. The fair value hierarchy gives the lowest priority to Level 3 inputs. The table below summarizes the fair values of financial liabilities as of October 31, 2024: SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES Fair Value at Fair Value Measurement Using October 31, 2024 Level 1 Level 2 Level 3 Derivative liabilities $ 1,019,644 $ - $ - $ 1,019,644 Fair values of financial liabilities as of April 30, 2024, are as follows: Fair Value at Fair Value Measurement Using April 30, 2024 Level 1 Level 2 Level 3 Derivative liabilities $ 740,940 $ - $ - $ 740,940 The following is a description of the valuation methodologies used for these items: Derivative liabilities The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value following A.S.C. Topic 825, “ The Fair Value Option for Financial Issuances

WARRANTS

WARRANTS	6 Months Ended
	Oct. 31, 2024
Warrants
WARRANTS	NOTE G – WARRANTS No warrants were issued to employees for services. Stock options totaling 290,000 11,812,708 204,385 2,574,603 0.30 0.55 2

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE H – COMMITMENTS AND CONTINGENCIES Operating Lease Commitments Our executive offices are located in New York, NY. We have an agreement for use of office space at this location under a sublease which expired on July 31, 2018 6,000 Rent expense was $ 18,000 18,000 Employment and Consulting Agreements The Company does not have employment agreements with any of its non-executive employees. The Company has consulting agreements with outside contractors to provide marketing and financial advisory services. The agreements are generally for 12 months from inception and renewable automatically from year to year unless the Company or consultant terminates such engagement by written notice. The Company entered into five-year employment agreements with its CEO, Anthony L Havens and Vice President of Operations, Sandra L Ahman. As part of their employment agreements, Mr. Havens received five year 376,256 0.308 three years five year 125,419 0.308 three years Litigation The Company is subject to legal proceedings and claims arising in its business’s ordinary course. Sparta can make no representations about the potential outcome of such proceedings. As of October 31, 2024, there is no pending litigation against Sparta and any and all prior litigation has been discontinued, settled or otherwise resolved with no liability whatsoever against Sparta.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Oct. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE I – SUBSEQUENT EVENTS The Company had evaluated subsequent events for recognition and disclosure as of the date the financial statements were available to be issued. Subsequent to October 31, 2024 the Company: ● Issued 1,496,451 232,000 ● Converted 12,000 36,000 ● Converted 30,000 120,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Business	Business General Overview Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation with headquarters in New York City, (www.spartacommercial.com) Sparta’s roots are in the Powersports industry. The Company provided retail installment loans and leases through authorized motorcycle dealerships in 33 states, with financing provided by institutional lenders. The Company also maintained a full underwriting and servicing platform for its portfolio. Notwithstanding the discontinuance of our initial focus on consumer loans and leases post Lehman and during the 2008 financial crisis, in 2007, the Company introduced a new initiative, Municipal Financing (www.spartamunicipal.com), which has financed over 100 jurisdictions to date. Sparta’s Municipal Finance program is available to all nonprofit organizations, institutions, and entities. All nonprofit organizations which adhere to I.R.S. guidelines, including 501 (c) 3 of the Internal Revenue Code, are eligible. Both public nonprofits, also known as public charities supported with publicly collected funds, and private nonprofits, also known as private foundations backed by an individual or business entity, qualify for the program.. Consumers, retailers, municipals, nonprofits, auction houses, banks, and insurance companies scrutinize title history reports for the vital information needed and factored into crucial business decisions affecting the bottom line. Vehicle History Reports are a staple of Sparta’s E-Commerce Technology subsidiary iMobile Solutions, Inc. Whether a vehicle is intended for business or recreational use, Sparta’s Vehicle History Reports are highly regarded for accuracy and completeness. They have been sold across all 50 states and in 62 countries worldwide. They provide a trusted layer of assurance to vehicle buyers and are available on our websites as well as on various dealership websites. They include Cyclechex (Motorcycle History Reports at www.cyclechex.com), RVchex (Recreational Vehicle History Reports at www.rvchex.com), and Truckchex (Heavy Duty Truck History Reports at www.truckchex.com The Company’s E-Commerce and Mobile Technology subsidiary name change to iMobile Solutions, Inc., from Specialty Reports, Inc., in 2016, signifies its ever-broadening service offerings in the evolving technology landscape. With iMobile App (www.imobileapp.com), the Company provides mobile technology services, including web and mobile application creation, development, and management for a wide range of businesses to increase revenue, build brand recognition, and improve customer engagement. Our ever-broadening business base of mobile applications includes vehicle dealerships and racetracks, private clubs and country clubs, schools and entertainment venues, restaurants, grocery stores, and various other merchant types. (www.imobileapp.com/app-gallery). The Company also designs, launches, maintains, and hosts websites for businesses incorporating SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development, and integration. This custom software helps businesses communicate with customers and can also be used for employees to communicate internally. The CRM software can be web-based, integrated with a mobile app, or both. We work with clients to understand their unique needs and incorporate the features and requirements that are most important to them and will facilitate their business growth and success. Correspondingly, the Company designs and builds custom kitchen ordering software for independent grocery stores, delicatessens, and other food service businesses. The software can be designed in various ways, including mobile devices and in-store ordering. The kitchen ordering software is enabled with payment integration, text messaging notification, wireless printing, and other features. iMobile Solutions, Inc. provides a turn-key solution for businesses looking to simplify or streamline their kitchen ordering process. Additionally, we offer text messaging services, which supplement business marketing strategies to gain and retain brand loyalty among its clients, customers, and investors. Our text messaging platform allows clients to manage, schedule, and analyze text message performance quickly. Sparta’s response to the onset of the COVID-19 pandemic in early 2020 quickly took shape with thorough investigations into evolving customer trends in health and wellness. As a result, we expanded New World Health Brands and developed a new product line of natural dietary supplements. In August 2020, we launched an online B to C website: www.newworldhealthbrands.com Sparta’s subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com, was established in September 2020, and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform is scheduled to launch in 2023 and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com Agoge Global USA, Inc. was formed as a subsidiary of Sparta Crypto, Inc. in December 2022 and entered into a Joint Venture Agreement with WeDev Group to facilitate cross-border transactions between importers and exporters of goods from the U.S. and Brazil. In addition, Agoge Global USA provides business intermediary services to global importers and exporters of goods and services. These services provided through our joint venture agreement with WeDev include, but are not limited to, industry introductions, tax and regulatory compliance assistance, import and export documentation assistance, reselling services in other jurisdictions, and facilitation of cross-border transactions.
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements as of October 31, 2024 and for the three months ended October 31, 2024 and 2023 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, including Form 10-Q and Regulation S-K. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments), which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. The Company believes that the disclosures provided are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and explanatory notes for the year ended April 30, 2024 as disclosed in the Company’s Form 10-K for that year as filed with the Securities and Exchange Commission on August 14, 2024. The results of operations for the three months ended October 31, 2024 are not necessarily indicative of the results to be expected for any other interim period or the full year ending April 30, 2025.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation. The third-party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of changes in deficit.
Estimates	Estimates These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and the disclosures of revenues and expenses for the said period. Accordingly, actual results could differ from those estimates.
Revenue Recognition	Revenue Recognition Revenue is recognized in accordance with Accounting Standards Codification (“ASC”) Revenue from Contracts with Customers The Company acts as a principal in its revenue transactions as it is the primary obligor. SCHEDULE OF DISAGGREGATION REVENUE Revenue October 31, 2024 July 31, 2024 Three months ended Revenue October 31, 2024 July 31, 2024 Information technology $ 27,695 $ 34,344 New World Health 6,120 5,062 Merchant financing 13,993 2,145 Total $ 47,808 $ 41,551 Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are typically recognized upon delivery/download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due before our performance, including refundable amounts. Revenues from merchant financing is recognized over the life of the contracts.
Cash Equivalents	Cash Equivalents All liquid investments with three months or less maturity are cash equivalents for the accompanying financial statements.
Website Development Costs	Website Development Costs The Company recognizes website development costs in accordance with ASC 350-50, “Accounting for Website Development Costs.”
Fair Value Measurements	Fair Value Measurements The Company has adopted ASC 820, “Fair Value Measurements .” ● Level 1 — ● Level 2 — ● Level 3 — This hierarchy requires the Company to use observable market data when available and to minimize the use of unobservable inputs when determining fair value. Observable inputs may not always be available for some products or in certain market conditions.
Income Taxes	Income Taxes We utilize ASC 740, “ Income Taxes The Company recognizes the impact of a position in the financial statements only if that position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position. Our practice recognizes interest or penalties related to income tax matters in income tax expense.
Stock-Based Compensation	Stock-Based Compensation We account for our stock-based compensation under ASC 718 “ Compensation–Stock Compensation We use the fair value method for equity instruments granted to non-employees and the Black-Scholes model to measure options’ fair value. The stock-based fair value compensation is determined as of the date of the grant or at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.
Inventories	Inventories The Company’s inventories represent finished goods, consisting of available products. They are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health business.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents, and receivables. The Company places its cash and temporary cash investments with high-credit quality institutions. At times, such investments may be more than the FDIC insurance limit.
Net Loss Per Share	Net Loss Per Share The Company uses ASC 260-10, “ Earnings Per Share
Derivative Liabilities	Derivative Liabilities The Company assessed the classification of its derivative financial instruments as of October 31, 2024, and April 30, 2024, which consist of convertible instruments and rights to shares of the Company’s common stock. It determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed conventional, as described.
Convertible Instruments	Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “ Accounting for Derivative Instruments and Hedging Activities The Company assessed the classification of its derivative financial instruments as of October 31, 2024 and April 30, 2024, which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.
Reclassifications	Reclassifications Certain reclassifications have been made to conform with prior periods’ data to the current presentation. These reclassifications did not affect reported losses.
Recent Accounting Pronouncements	Recent Accounting Pronouncements No recent pronouncements have been made or adopted in the quarter ended October 31, 2024. All of the pronouncements that affect our business have been adopted.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
SCHEDULE OF DISAGGREGATION REVENUE	The Company acts as a principal in its revenue transactions as it is the primary obligor. SCHEDULE OF DISAGGREGATION REVENUE Revenue October 31, 2024 July 31, 2024 Three months ended Revenue October 31, 2024 July 31, 2024 Information technology $ 27,695 $ 34,344 New World Health 6,120 5,062 Merchant financing 13,993 2,145 Total $ 47,808 $ 41,551

NOTES PAYABLE AND DERIVATIVES (

NOTES PAYABLE AND DERIVATIVES (Tables)	6 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE	The Company has numerous outstanding notes payable to various parties. The notes bear interest at rates of 5 20 SCHEDULE OF NOTES PAYABLE Notes Payable October 31, 2024 April 30, 2024 Notes convertible at holder’s option $ 2,231,197 $ 2,723,197 Notes convertible at Company’s option 335,700 335,700 Non-convertible notes payable 2,913,400 2,399,221 Accrued interest 2,005,196 1,710,363 Notes payable current 7,485,493 7,168,481 Add non-current portion 341,829 - Total $ 7,827,322 $ 7,168,481
SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BINOMIAL OPTION	The change in fair value of the derivative liabilities on October 31, 2024, was calculated with the following average assumptions using a binomial option pricing model are as follows: SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BINOMIAL OPTION Significant Assumptions: Risk-free interest rate 4.28 % Expected stock price volatility 125 % Expected dividend payout 0 Expected life in years 1
SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES	Changes in derivative liability during the three months ended October 31, 2024, and 2023 were: 1,019,644 SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES October 31, October 31, 2024 2023 Balance, beginning of year $ 1,119,232 $ 1,375,767 Balance $ 1,119,232 $ 1,375,767 Derivative liability extinguished - (100,797 ) Derivative financial liability arising on the issuance of convertible notes and warrants - - Fair value adjustments (99,588 ) (76,576 ) Balance, end of period $ 1,019,644 $ 1,198,394 Balance $ 1,019,644 $ 1,198,394

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES	The table below summarizes the fair values of financial liabilities as of October 31, 2024: SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES Fair Value at Fair Value Measurement Using October 31, 2024 Level 1 Level 2 Level 3 Derivative liabilities $ 1,019,644 $ - $ - $ 1,019,644 Fair values of financial liabilities as of April 30, 2024, are as follows: Fair Value at Fair Value Measurement Using April 30, 2024 Level 1 Level 2 Level 3 Derivative liabilities $ 740,940 $ - $ - $ 740,940

SCHEDULE OF DISAGGREGATION REVE

SCHEDULE OF DISAGGREGATION REVENUE (Details) - USD ($)	3 Months Ended			6 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Product Information [Line Items]
Total	$ 47,808	$ 41,551	$ 52,418	$ 89,359	$ 114,697
Information Technology [Member]
Product Information [Line Items]
Total	27,695	34,344	42,875	62,039	98,071
New World Health [Member]
Product Information [Line Items]
Total	6,120	5,062
Merchant Financing [Member]
Product Information [Line Items]
Total	$ 13,993	$ 2,145		$ 16,138

GOING CONCERN MATTERS (Details

GOING CONCERN MATTERS (Details Narrative) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 68,176,055	$ 66,795,350
Working capital deficit	$ 9,833,834

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Short-Term Debt [Line Items]
Notes payable current	$ 7,485,493	$ 7,168,481
Add non-current portion	341,829
Total	7,827,322	7,168,481
Notes Convertible at Holder's Option [Member]
Short-Term Debt [Line Items]
Notes payable current	2,231,197	2,723,197
Notes Convertible at Company's Option [Member]
Short-Term Debt [Line Items]
Notes payable current	335,700	335,700
Non-convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Notes payable current	2,913,400	2,399,221
Accrued Interest [Member]
Short-Term Debt [Line Items]
Notes payable current	$ 2,005,196	$ 1,710,363

SCHEDULE OF DERIVATIVE LIABILIT

SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BINOMIAL OPTION (Details)	6 Months Ended
	Oct. 31, 2024
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input, expected dividend payout	4.28
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input, expected dividend payout	125
Measurement Input Dividend Payout [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input, expected dividend payout	0
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input, expected life	1 year

SCHEDULE OF CHANGES IN DERIVATI

SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details) - USD ($)	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024
Debt Disclosure [Abstract]
Derivative liabilities current	$ 1,019,644		$ 740,940
Balance	1,119,232	$ 1,375,767
Derivative liability extinguished		(100,797)
Derivative financial liability arising on the issuance of convertible notes and warrants
Fair value adjustments	(99,588)	(76,576)
Balance	$ 1,019,644	$ 1,198,394

NOTES PAYABLE AND DERIVATIVES_2

NOTES PAYABLE AND DERIVATIVES (Details Narrative)	6 Months Ended
	Oct. 31, 2024
Debt Instrument [Line Items]
Common stock discount rate, percentage	60%
Minimum [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate	5%
Maximum [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate	20%

LOANS PAYABLE TO RELATED PART_2

LOANS PAYABLE TO RELATED PARTIES (Details Narrative) - Officers, Directors, and Other Related Parties [Member] - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Related Party Transaction [Line Items]
Loans and notes payable	$ 635,319	$ 637,077
Minimum [Member]
Related Party Transaction [Line Items]
Interest rate	0%
Maximum [Member]
Related Party Transaction [Line Items]
Interest rate		12%

EQUITY TRANSACTIONS (Details Na

EQUITY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended				6 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Oct. 31, 2023	Jul. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024
Class of Stock [Line Items]
Preferred stock, shares designated	10,000,000				10,000,000		10,000,000
Preferred stock, par value	$ 0.001				$ 0.001		$ 0.001
Common stock, shares authorized	750,000,000				750,000,000		750,000,000
Common stock, par value	$ 0.001				$ 0.001		$ 0.001
Common stock, shares issued	36,210,837				36,210,837		29,495,189
Common stock, shares outstanding	36,210,837				36,210,837		29,495,189
Common classified to be issued	33,490,238				33,490,238		33,395,883
Number of shares issued during period, value	$ 212,500	$ 335,000	$ 65,000	$ 105,000
Number of shares issued services, value	55,016	23,000	3,875	69,169
Number of shares issued convertible securities, value	$ 10,000	$ 75,000
Incentive Noteholders [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares						75,000
Number of shares issued during period, value						$ 6,975
Convertible Notes [Member]
Class of Stock [Line Items]
Number of shares issued convertible securities, shares					850,000
Number of shares issued convertible securities, value					$ 85,000
Consulting Services [Member]
Class of Stock [Line Items]
Number of shares issued services, shares					153,956	25,000
Number of shares issued services, value					$ 55,016	$ 3,875
Common Stock [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares	50,014	1,971,673
Number of shares issued during period, value	$ 50	$ 1,972
Number of shares issued services, shares	153,956	200,000	25,000	830,906
Number of shares issued services, value	$ 154	$ 200	$ 25	$ 831
Number of shares issued convertible securities, shares	100,000	750,000
Number of shares issued convertible securities, value	$ 100	$ 750
Common Stock to be Issued [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares	1,315,923	1,813,590	988,000	1,132,910
Number of shares issued during period, value	$ 1,999	$ 1,814	$ 988	$ 1,133
Number of shares issued services, shares				(830,906)
Number of shares issued services, value				$ (831)
Number of shares issued convertible securities, value
Accredited Investors [Member] | Common Stock [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares					3,043,232
Number of shares to be issued during period, shares					2,107,968
Number of shares issued during period, value					$ 547,500
Incentive Noteholders [Member] | Common Stock to be Issued [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares					579,847
Number of shares issued during period, value					$ 42,890
Four Accredited Investors [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares						1,178,251
Number of shares issued during period, value						$ 95,000
Five Accredited Investors [Member] | Common Stock to be Issued [Member]
Class of Stock [Line Items]
Number of shares issued during period, shares						1,127,372
Number of shares issued during period, value						$ 85,000
Series A Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated	35,850				35,850		35,850
Preferred stock, par value	$ 100				$ 100		$ 100
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated	1,000				1,000
Liquidation value	$ 10,000				$ 10,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated	4,200,000				4,200,000
Liquidation value per share	$ 1				$ 1
Series D Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated	2,000,000				2,000,000
Liquidation value per share	$ 1				$ 1

SCHEDULE OF FAIR VALUES OF FINA

SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 1,019,644	$ 740,940
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 1,019,644	$ 740,940

WARRANTS (Details Narrative)

WARRANTS (Details Narrative) - USD ($)	6 Months Ended	12 Months Ended
	Oct. 31, 2024	Apr. 30, 2024
Options vested		11,812,708
Fair value adjustment of warrants		$ 204,385
Warrants and rights outstanding, term	2 years
Minimum [Member]
Warrants exercisable, per share	$ 0.30
Maximum [Member]
Warrants exercisable, per share	$ 0.55
Warrant [Member]
Number of shares issued warrants exercisable, shares	2,574,603
Employees [Member]
Options issued for service provided		290,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024
Property, Plant and Equipment [Line Items]
Rent expense	$ 18,000	$ 18,000
Employment Agreement [Member] | Mr. Havens [Member]
Property, Plant and Equipment [Line Items]
Options term			5 years
Shares issuable upon option exercise			376,256
Share price per share	$ 0.308		$ 0.308
Options vesting period			3 years
Employment Agreement [Member] | Ms. Ahman [Member]
Property, Plant and Equipment [Line Items]
Options term			5 years
Shares issuable upon option exercise			125,419
Share price per share	$ 0.308		$ 0.308
Options vesting period			3 years
Executive Office Space [Member]
Property, Plant and Equipment [Line Items]
Lease expiring date			Jul. 31, 2018
Rent expense			$ 6,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]	Nov. 01, 2024 USD ($) shares
Subsequent Event [Line Items]
Number of shares issued	1,496,451
Investors related to equity investments | $	$ 232,000
Series C Preferred Stock [Member]
Subsequent Event [Line Items]
Conversion of notes payable, shares	12,000
Converted shares	36,000
Series D Preferred Stock [Member]
Subsequent Event [Line Items]
Conversion of notes payable, shares	30,000
Converted shares	120,000